[{"id":6197,"regimens":[{"id":11833,"duration":{"id":5831,"approximate_duration":"3 days","dates_unknown":true},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":8908,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11833},{"id":8909,"answer":"In a novel combination with another drug","answer_other":"","regimen":11833}],"created":"2020-10-06T18:14:44.791300Z","updated":"2020-10-16T13:44:23.613437Z","dose":"500mg","frequency":"BID","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6197},{"id":11834,"duration":{"id":5832,"approximate_duration":"3 days","dates_unknown":true},"drug":{"id":10130,"name":"Ribavirin","url":"cure-api2.ncats.io/v1/drugs/10130","rxNorm_id":null,"notes":null},"use_drug":[{"id":8910,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11834},{"id":8911,"answer":"In a novel combination with another drug","answer_other":"","regimen":11834}],"created":"2020-10-06T18:14:44.799480Z","updated":"2020-10-16T13:44:23.619791Z","dose":"1000 mg","frequency":"QD","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6197},{"id":11837,"duration":{"id":5835,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6122,"name":"Azithromycin","url":"cure-api2.ncats.io/v1/drugs/6122","rxNorm_id":null,"notes":null},"use_drug":[{"id":8914,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11837},{"id":8915,"answer":"In a novel combination with another drug","answer_other":"","regimen":11837}],"created":"2020-10-06T18:14:44.818740Z","updated":"2020-10-16T13:44:23.625361Z","dose":"500 mg","frequency":"QD","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6197},{"id":11838,"duration":{"id":5836,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7535,"name":"Drotaverine","url":"cure-api2.ncats.io/v1/drugs/7535","rxNorm_id":null,"notes":null},"use_drug":[{"id":8916,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11838},{"id":8917,"answer":"In a novel combination with another drug","answer_other":"","regimen":11838}],"created":"2020-10-06T18:14:44.824890Z","updated":"2020-10-16T13:44:23.631180Z","dose":"40mg","frequency":"BID","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6197},{"id":11839,"duration":{"id":5837,"approximate_duration":null,"dates_unknown":false},"drug":{"id":5905,"name":"Amoxicillin-Clavulanate","url":"cure-api2.ncats.io/v1/drugs/5905","rxNorm_id":null,"notes":null},"use_drug":[{"id":8918,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11839},{"id":8919,"answer":"In a novel combination with another drug","answer_other":"","regimen":11839}],"created":"2020-10-06T18:38:44.626467Z","updated":"2020-10-16T13:44:23.636857Z","dose":"1 gram","frequency":"Q12H","route":"PO","severity":"Inpatient","severity_detail":"","comments":null,"report":6197}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8134,"answer":"Clinical assessment","answer_other":"","report":6197},{"id":8135,"answer":"PCR","answer_other":"","report":6197}],"how_diagnosis":[{"id":13843,"answer":"PCR","answer_other":"","report":6197},{"id":13844,"answer":"Clinical assessment","answer_other":"","report":6197},{"id":13845,"answer":"Imaging","answer_other":"","report":6197},{"id":13846,"answer":"Serology","answer_other":"","report":6197}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4224,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6197},{"id":4225,"answer":"Unusual disease presentation","answer_other":"","report":6197}],"adverse_event_outcome":[{"id":75,"answer":"Non-Serious Medical Event","report":6197}],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-10-06T18:05:14.239979Z","updated":"2020-10-16T13:44:23.605402Z","title":"Gastrointestinal symptoms as the first, atypical indication of severe acute respiratory syndrome coronavirus 2 infection.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32250094,"doi":"10.20452/pamw.15278","article_url":"https://pubmed.ncbi.nlm.nih.gov/32250094/","pub_year":2020,"published_authors":"Pazgan-Simon M\r\nRorat M\r\nBuczyńska I\r\nZińczuk A\r\nSimon K","article_author_email":"monika.pazgan.simon@gmail.com","journal":"Polish archives of internal medicine","abstract":"The presented case is an example of an unusual course of SARS-CoV-2 infection, initially masked by gastrointestinal symptoms. It is difficult to assess the possible positive effect of antiviral treatment with lopinavir/ritonavir and ribavirin on the course of COVID-19 in our patient, as the therapy was used during a short time.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"61-70 years","sex":"Female","ethnicity":null,"country_contracted":"Italy","country_treated":"Poland","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Gastrointestinal, Lungs","clinical_syndrome":"Pneumonia, diffuse abdominal and back pain","severity":"Inpatient","prev_treatment":"","unusual":"The presented case is an example of an unusual course of SARS-CoV-2 infection, initially masked by gastrointestinal symptoms. Clinical (cough, dyspnea) and radiologic (interstitial consolidations in the peripheral parts of the lungs) symptoms appeared only on day 7, after the occurrence of abdominal pain.","drug_treatment_features":"","have_adverse_events":true,"adverse_events":"The therapy of lopinavir/ritonavir and ribavirin was abandoned after 3 days due to drug intolerance manifested by diarrhea, nausea, vomiting, and abdominal pain.","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"The patient was treated with oxygen therapy, 1 g of amoxicillin and clavulanic acid administered orally every 12 hours, 500 mg of azithromycin once a day, and 40 mg of drotaverine twice a day. During hospitalization, abdominal pain subsided, dry and paroxysmal cough intensified, and slight dyspnea appeared (oxygen saturation, 90%). \r\n\r\nAs the patient’s condition deteriorated and progressive inflammatory lesions were seen on repeated chest X-ray, treatment with lopinavir/ritonavir and ribavirin was started.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[5905,6122,7535,8783,10130]}]